Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Viking Therapeutics (VKTX) Equity Ratio (2016 - 2025)

Viking Therapeutics (VKTX) has disclosed Equity Ratio for 12 consecutive years, with 0.89 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 7.87% to 0.89 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.89 through Dec 2025, down 7.87% year-over-year, with the annual reading at 0.89 for FY2025, 7.87% down from the prior year.
  • Equity Ratio hit 0.89 in Q4 2025 for Viking Therapeutics, down from 0.96 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.98 in Q1 2025 to a low of 0.86 in Q4 2022.
  • Historically, Equity Ratio has averaged 0.94 across 5 years, with a median of 0.95 in 2021.
  • Biggest five-year swings in Equity Ratio: dropped 10.02% in 2022 and later grew 9.65% in 2023.
  • Year by year, Equity Ratio stood at 0.96 in 2021, then decreased by 10.02% to 0.86 in 2022, then rose by 9.65% to 0.95 in 2023, then grew by 2.5% to 0.97 in 2024, then decreased by 7.87% to 0.89 in 2025.
  • Business Quant data shows Equity Ratio for VKTX at 0.89 in Q4 2025, 0.96 in Q3 2025, and 0.96 in Q2 2025.